The hyperactivated IL6/JAK/STAT3 can facilitate tumor cell proliferation and invasiveness; hence treatments targeting the IL6/JAK/STAT3 pathway are expected to inhibit tumor cell growth [43]. Here, IL6 is linked to neoplasm.